Unbiased Analysis of Today's Healthcare Issues
ISPOR Europe kicks off this week in Barcelona, Spain. In honor of ISPOR, I will summarize some key attributes of the Spanish health care system based on a 2024 report from the European Observatory on Health Systems and Policies and the Instituto Aragones de Ciencias de la Salud. Country overview Population: 48.4 million (as of…
This question is particularly relevant with the passage of the Inflation Reduction Act (IRA) and the requirement that CMS negotiate a ‘maximum fair price’ for drugs with the biggest impact on Medicare’s bottom line. A Health Affairs Forefront paper by Lin et al. (2023) compares how drug price negotiation differs between Canada, France, Germany and…
According to the OECD, In 2021 the U.S. spent $1,432/capita on pharmaceuticals compared to only $517/per capita in the UK. The UK’s figure was slightly higher that Poland and Norway, but less than Latvia, the Slovak Republic, Portugal and Romania. How does the UK spend so little on drugs? Many people focus on the efforts…
Out recently is an interesting AEA paper by Okeke 2023, who examines a policy experiment by the Nigerian government that aimed determine whether expand access to physicians improved health outcomes. In this experiment, some communities were randomly selected to receive a new doctor. These doctors were posted to the local public health center. Prior to…
The value of medical devices caries with it less certainty than pharmaceuticals for a variety of reasons. As described in Kovács et al. (2022) medical devices: often have multiple applications, frequently, undergo product modifications and during their product lifecycle, multiple incremental technological innovations take place affecting both clinical and economic consequences of their adoption into…
How well do different countries take care of their elderly and near elderly populations? A study by Macinko et al. (2020) provides some useful statistics. Methods Population of interest. Individuals aged 50 and above sampled across 23 high- and middle-income countries. Data. The data come from 2015 or 2016 years for the following data sets:…
If you are hurt and can’t work to make money, what do you do? In most countries, disabled individuals are eligible for disability insurance. However, the rate of individuals who claim disability insurance varies greatly across countries. Is this largely due to differences in country population characteristics or disability policy generosity? This is the question…
Health technology assessments (HTAs) aim to measure the cost effectiveness of a given treatment or set of treatments for a specific patient populations. Often, these assessments are conducted from the point of view of the payer–either a national health system or the individual insurer perspective. This payer focused perspective can often focus largely on treatment costs rather…
There has been a lot of criticism of drug prices in the U.S. One person not included the chorus of critics is Bill Gates. In an interview with Bloomberg, he said: “The current system is better than most other systems one can imagine,” Gates said in an interview on Bloomberg Television. “The drug companies are…
Malaysia is a middle income country (GDP per capita $26,600, about half of U.S. income levels) of 30.5 million people (about the population of New York and Ohio combined). Life expectancy is 74.75 years, just 5 years below the U.S. Health spending in Mayalsia is only 4% of GDP (compared to 17% of GDP in…